Sulfamethoxypyridazine
Chemical compound
- J01ED05 (WHO) QJ01EQ15 (WHO)
- 4-amino-N-(6-methoxypyridazin-3-yl)benzenesulfonamide
- 80-35-3 N
- 5330
- 5139 Y
- T034E4NS2Z
- D02439 Y
- CHEBI:102516 Y
- ChEMBL268869 Y
- DTXSID5023611
- Interactive image
- O=S(=O)(Nc1nnc(OC)cc1)c2ccc(N)cc2
InChI
- InChI=1S/C11H12N4O3S/c1-18-11-7-6-10(13-14-11)15-19(16,17)9-4-2-8(12)3-5-9/h2-7H,12H2,1H3,(H,13,15) Y
- Key:VLYWMPOKSSWJAL-UHFFFAOYSA-N Y
Sulfamethoxypyridazine is a sulfonamide antibacterial.[1]
It is prescribed for vaginal irritation, and severe acute thrush.
It is also used in the treatment of Dermatitis herpetiformis,[2] where it is an alternative therapy to Dapsone.
Sulfamethoxypyridazine is supplied as 500mg tablets.
References
- ^ Boger WP, Gylfe JM, Strickland CS (November 1956). "Sulfamethoxypyridazine (Kynex), a new long-acting sulfonamide". Antibiotic Medicine & Clinical Therapy. 3 (6). New York, NY: 378–87. PMID 13363378.
- ^ Vilanova X, De Moragas JM (October 1959). "[Treatment of dermatitis herpetiformis (Duhring) and herpes gestationis with sulfamethoxypyridazine]". Actas Dermo-sifiliograficas (in Spanish). 50: 439–42. PMID 13842251.
- v
- t
- e
(inhibit bacterial
purine metabolism,
thereby inhibiting
DNA and RNA
synthesis)
DHFR inhibitor | |||||||||
---|---|---|---|---|---|---|---|---|---|
Sulfonamides (DHPS inhibitor) |
| ||||||||
Combinations |
| ||||||||
Other DHPS inhibitors |
(inhibit bacterial
topoisomerase
and/or DNA gyrase,
thereby inhibiting
DNA replication)
1st generation | |||||||||
---|---|---|---|---|---|---|---|---|---|
Fluoroquinolones |
| ||||||||
Newer non-fluorinated | |||||||||
Related (DG) |
inhibitors
Nitroimidazole derivatives | |
---|---|
Nitrofuran derivatives |
Rifamycins/ RNA polymerase | |
---|---|
Lipiarmycins |
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This systemic antibiotic-related article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e